Supplemental Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($) |
Mar. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Schedule of Accrued Expenses and Other Current Liabilities [Abstract] | |||
| Accrued research and development expenses | $ 4,043,237 | $ 1,449,646 | $ 856,144 |
| Accrued compensation expenses | 1,357,606 | 785,230 | |
| Accrued legal expenses | 377,279 | 58,767 | |
| Accrued stock issuance expenses | 400,000 | ||
| Accrued accounting fees | 83,187 | ||
| Accrued expenses and other current liabilities | $ 6,261,309 | $ 2,293,643 | $ 856,144 |